Clinical characteristics and incidence of infectious and non-infectious endophthalmitis after intra vitreous injection of triamcinolone acetonide;Avaliação clínica e incidência de endoftalmite infecciosa e não-infecciosa após injeção intravítrea de acetonida de triancinolona

Arquivos Brasileiros de Oftalmologia

Volumn 69, Issue 6, 2006, Pages 791-794

  Magalhães, Érika ^a   Nehemy, Patrícia ^a   de Vasconcelos Santos, Daniel Vítor ^a   Fujji, Gildo ^a,b   Nehemy, Márcio Bittar ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Choroid; Endophthalmitis; Eye infections; Injections; Retinal diseases; Triamcinolone acetonide; Vitreous body

Indexed keywords

EID: 33846818684     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492006000600003     Document Type: Article

References (21)

1. Hood PP, Cotter TP, Costello JF, Sampson AP. Effect of intravenous corticosteroid on ex vivo leukotriene generation by blod leucocytes of normal and asthmatic patients. Thorax. 1999;54(12):1075-82.
2. Scott IU, Flynn HW Jr, Rosenfeld PJ. Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema. Am J Ophthalmol. 2003;136(4):737-9.
3. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol. 2003;136(2):384-6. Comment in: Am J Ophthalmol. 2003;136(6):575-6; author reply 1192-3.
4. Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol. 2003;135(2):246-9.
5. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol. 2003;121(1): 57-61. Comment in: Arch Ophthalmol. 2004;122(7):1082-3; author reply 1086-8. Arch Ophthalmol. 2004;122(7):1082; author reply 1086-8. Arch Ophthalmol. 2004;122(7):1083-5; author reply 1086-8. Arch Ophthalmol. 2004; 122(7):1083; author reply 1086-8. Arch Ophthalmol. 2004;122(7):1085-6; author reply 1086-8.
6. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109(5):920-7.
7. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol. 2001;132(3):425-7.
8. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol. 2002;86(2):247-8
9. Godoy G, Finamor LP, Andrade R, Muccioli C. Triancinolona intravítrea em vasculite retiniana - relato de caso. Arq Bras Oftalmol. 2004;67(6):953-6.
10. Rechtman E, Allen VD, Danis RP, Pratt LM, Harris A, Speicher MA. Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. Am J Ophthalmol. 2003;136(4):739-41.
11. Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF. Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol. 2004;122(2):218-22.
12. Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W, et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol. 2003;121(5):667-73. Comment in: Arch Ophthalmol. 2004;122(10): 1571-2; author reply 1572.
13. Spaide RF, Sorenson J, Maranan I. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology. 2003;110(8):1517-25.
14. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol. 2003;87(4):462-8.
15. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina, 2004;24(5):676-98.
16. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry N. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol. 2003;121(9):1279-82. Comment in: Arch Ophthalmol. 2004;122(11):1733; author reply 1733.
17. Sutter FK, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthatmol. 2003;87(8):972-4.
18. Wingate RJ, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol. 1999;27(6);431-2.
19. Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol. 2003;136(5):791-6. Comment in: Am J Ophthalmol. 2003; 136(5):918-9. Am J Ophthalmol. 2004;137(6):1158-9; author reply 1160-1. Am J Ophthalmol. 2004;137(6):1159-60; author reply 1160-1. Am J Ophthalmol. 2004;137(6):1166; author reply 1167.
20. Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina. 2003;23(5):686-9
21. Johnson MW, Doft BH, Kelsey SF, Barza M, Wilson LA, Barr CC, Wisniewski SR. The Endophthalmitis Vitrectomy Study Group. The Endophthalmitis Vitrectomy Study Group: Relationship between clinical presentation and microbiological spectrum. Ophthalmology, 1997;104(2):261-72.